Stay updated on Filgotinib and Lanraplenib in Female CLE Clinical Trial

Sign up to get notified when there's something new on the Filgotinib and Lanraplenib in Female CLE Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Filgotinib and Lanraplenib in Female CLE Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment notice indicating no participants are being sought. It also updates the Intervention/Treatment label formatting and the site revision from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T20:47:10.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now shows a new software revision label (v3.5.5) in place of the previous one (v3.5.4), reflecting a software version update to the page rendering.
    Difference
    0.0%
    Check dated 2026-06-08T17:16:24.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Lakefront Biotherapeutics NV was added as a collaborator and Galapagos NV was removed from the study's Collaborators and Investigators list.
    Difference
    0.0%
    Check dated 2026-05-25T10:22:38.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, indicating a small platform update.
    Difference
    0.0%
    Check dated 2026-05-18T04:15:30.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page’s site revision/version indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-26T15:31:27.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T13:50:18.000Z thumbnail image

Stay in the know with updates to Filgotinib and Lanraplenib in Female CLE Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Filgotinib and Lanraplenib in Female CLE Clinical Trial page.